BiochemistrybioRxivPreprint
Activity-based profiling of primary brain cells identifies covalent allosteric modulators of HCN channels
Elva Ye, Alberto Russo, Roberta Castelli…·Benjamin F. Cravatt
DOI 10.64898/2026.08.25.747126
Author
Anna Moroni
University of MilanORCID 0000-0002-1860-406XUnclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2022-2026 · peak 2/yrCo-Author Collaboration Network
10 top collaborators · 37 mutual co-author linksFocal author (center)Selected co-authorORCID co-authorUnlinked name
Curved chords = mutual co-authorship5 papers
Recent·Most cited
- PathologybioRxivPreprint
Comprehensive classification of HCN1 variants linked to neurodevelopmental disorders with and without epilepsy
Roberta Castelli, Carla Marini, Alessandro Porro…·Anna Moroni
This study functionally classifies HCN1 variants in patients with neurodevelopmental disorders, finding genotype-phenotype correlations and potential therapeutic targets.
DOI 10.64898/2026.03.18.712601 - BiophysicsJournal of PainPeer-reviewed
A synthetic potassium channel reduces oxidative stress 1 via cellular adaptronics
Rajesh Khanna, Alberto Russo, Andrea Saponaro…·Anna Moroni
The paper introduces a synthetic potassium channel that senses and mitigates oxidative stress by modulating membrane potential in cells and organelles.
- BiophysicsbioRxivPreprint
Animal-free recombinant nanobody rescues HCN4 channel deficit in sinus node dysfunction
Atiyeh Sadat Sharifzadeh, Roberta Castelli, Alessandro Porro…·Anna Moroni
This study identifies a recombinant nanobody that specifically activates HCN4 channels and rescues sinus node dysfunction in a patient with a loss-of-function mutation.
- NeuroscienceeLifePeer-reviewed
Seizures, behavioral deficits and adverse drug responses in two new genetic mouse models of HCN1 epileptic encephalopathy
Andrea Merseburg, Jacquelin Kasemir, Eric W. Buss…·Bina Santoro
This study presents two genetic mouse models of HCN1 epileptic encephalopathy, showing seizure susceptibility and adverse drug responses, highlighting the need for tailored therapies.
20 citations